Global Tissue & Biospecimen Leaders
Major providers with comprehensive tissue portfolios and global infrastructure
BioIVT
Global leader in biological products. Human tissues, matrices, cells, and fluids. ADME-Tox services. 11,000+ customers.
Discovery Life Sciences
Biospecimen and biomarker services. 20M+ biospecimens. Global procurement network. Acquired multiple biobanks.
iQ Biosciences
Human biospecimens and PBMC isolation. California-based. Donor recruitment specialists.
Cureline
Human tissue collection and molecular services. Patient tissue procurement. San Francisco Bay Area.
Reconstructed Human Tissue Models
Companies providing standardized, reconstructed human tissue models
MatTek Corporation
EpiDerm, EpiAirway, and EpiIntestinal models. 35+ years. OECD-validated for regulatory testing.
EpiSkin
Reconstructed skin models. L'Oréal subsidiary. EpiSkin and SkinEthic brands. Regulatory-accepted.
Phenion
Full-thickness skin models. Henkel subsidiary. FT Skin Model for consumer product testing.
Stratatech (Mallinckrodt)
StrataGraft bioengineered skin. FDA-approved for burns. Acquired by Mallinckrodt.
Primary Human Cell Specialists
Companies specializing in isolated primary human cells
Lonza Bioscience
Primary cells, media, and transfection. Part of Lonza Group. Global cell culture leader.
ScienCell Research
Primary cells and cell culture media. 300+ cell types. California-based supplier.
Lifeline Cell Technology
Primary human cells and media. Dermal, epithelial, and vascular cells. Optimized culture systems.
Zen-Bio
Human adipose-derived cells and tissues. Metabolic research specialists. North Carolina-based.
Integrated Research Services
Companies offering tissue procurement with research services
Kirkstall
Quasi Vivo perfusion systems. UK-based. Long-term tissue culture for ADME studies.
Tissue Solutions
Fresh human tissue procurement. Glasgow-based. Surgical tissue collection network.
Hepion Pharmaceuticals
Human liver tissue research. NASH-focused biotech with tissue access capabilities.
Asterand (BioIVT)
Human tissue research. Now part of BioIVT. Disease tissue collections.
Sector Analysis
Market Overview
- + Human tissue market projected to reach $3.5B by 2030 (8% CAGR)
- + PE consolidation creating larger full-service providers
- + FDA Modernization Act driving demand for human tissue models
- + Integration with organ-on-chip and organoid platforms
- + Ethical sourcing and traceability becoming critical differentiators
Explore More Categories
Discover companies across all human-relevant technology sectors